CA2286183A1 - Compositions and methods for inhibiting light-induced inactivation of biological reagents - Google Patents

Compositions and methods for inhibiting light-induced inactivation of biological reagents Download PDF

Info

Publication number
CA2286183A1
CA2286183A1 CA002286183A CA2286183A CA2286183A1 CA 2286183 A1 CA2286183 A1 CA 2286183A1 CA 002286183 A CA002286183 A CA 002286183A CA 2286183 A CA2286183 A CA 2286183A CA 2286183 A1 CA2286183 A1 CA 2286183A1
Authority
CA
Canada
Prior art keywords
compositions
methods
biological reagent
biological reagents
inhibiting light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002286183A
Other languages
French (fr)
Other versions
CA2286183C (en
Inventor
Kenneth F. Buechler
Paul H. Mcpherson
Alfred R. Sundquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286183A1 publication Critical patent/CA2286183A1/en
Application granted granted Critical
Publication of CA2286183C publication Critical patent/CA2286183C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Abstract

Disclosed is a fluorescent conjugate comprising a biological reagent, a fluorescent molecule, and a means for impeding phototoxic degradation of the biological reagent. The impeding means can be a cross-linking substance having a long molecular distance, whereby the cross-linking substance links the fluorescent molecule and the biological reagent; a quencher of singlet oxygen; a quencher of a free radical; or a combination thereof. Also disclosed is a solution comprising a fluorescent conjugate of a biological reagent and a fluorescent molecule together with an oxygen depleting system.
CA002286183A 1997-04-09 1998-04-06 Compositions and methods for inhibiting light-induced inactivation of biological reagents Expired - Lifetime CA2286183C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/837,309 US6544797B1 (en) 1997-04-09 1997-04-09 Compositions and methods for inhibiting light-induced inactivation of biological reagents
US08/837,309 1997-04-09
PCT/US1998/006793 WO1998045705A2 (en) 1997-04-09 1998-04-06 Compositions and methods for inhibiting light-induced inactivation of biological reagents

Publications (2)

Publication Number Publication Date
CA2286183A1 true CA2286183A1 (en) 1998-10-15
CA2286183C CA2286183C (en) 2008-11-18

Family

ID=25274130

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286183A Expired - Lifetime CA2286183C (en) 1997-04-09 1998-04-06 Compositions and methods for inhibiting light-induced inactivation of biological reagents

Country Status (8)

Country Link
US (2) US6544797B1 (en)
EP (1) EP0972194B1 (en)
JP (1) JP2001519908A (en)
AT (1) ATE244404T1 (en)
AU (1) AU6796598A (en)
CA (1) CA2286183C (en)
DE (1) DE69816051T2 (en)
WO (1) WO1998045705A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799839A1 (en) * 2000-02-02 2001-04-20 Commissariat Energie Atomique Determining antioxidant capacity of compounds, useful for assessing them for e.g. pharmaceutical application, based on inhibition of covalent reaction mediated by reactive oxygen species
US6800068B1 (en) * 2001-10-26 2004-10-05 Radiant Medical, Inc. Intra-aortic balloon counterpulsation with concurrent hypothermia
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
US20040241880A1 (en) * 2003-05-30 2004-12-02 Leproust Eric M. Ligand array assays having reduced fluorescent dye degradation and compositions for practicing the same
US20040241742A1 (en) * 2003-05-30 2004-12-02 Peck Bill J. Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
GB0424294D0 (en) * 2004-11-03 2004-12-01 Elam T Ltd Buffer layer
EP1828412B2 (en) * 2004-12-13 2019-01-09 Illumina Cambridge Limited Improved method of nucleotide detection
GB0427236D0 (en) 2004-12-13 2005-01-12 Solexa Ltd Improved method of nucleotide detection
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20100311186A1 (en) * 2006-07-28 2010-12-09 Biosite Incorporated Devices and methods for performing receptor binding assays using magnetic particles
US20090043109A1 (en) * 2007-08-07 2009-02-12 Spangler Brenda D Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source
US20090062386A1 (en) * 2007-08-30 2009-03-05 Clean Earth Technologies, Llc Simulants of Toxants for Training and Testing
US20090057622A1 (en) * 2007-08-31 2009-03-05 Clean Earth Technologies, Llc Simulant of Radiological Contamination
EP2252625B1 (en) * 2008-02-07 2017-12-20 Pacific Biosciences of California, Inc. Cis reactive oxygen quenchers integrated into linkers
WO2009114182A1 (en) 2008-03-13 2009-09-17 Pacific Biosciences Of California, Inc. Labeled reactants and their uses
US8388982B2 (en) * 2008-11-19 2013-03-05 Pacific Biosciences Of California, Inc. Photo-induced damage mitigating agents and preparation and methods of use thereof
DE102009010563A1 (en) 2009-02-16 2010-08-26 Matthias W. Engel Device for the detection of analytes in body fluids
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
WO2012021733A2 (en) 2010-08-12 2012-02-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US8906612B2 (en) 2010-08-25 2014-12-09 Pacific Biosciences Of California, Inc. Scaffold-based polymerase enzyme substrates
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US8835000B2 (en) * 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
DE102012102082B3 (en) * 2012-03-13 2013-03-21 Thyssenkrupp Rasselstein Gmbh A method of treating a metal-coated steel strip or sheet with an aftertreatment agent and a steel strip or sheet provided with a metal coating.
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
US10458915B2 (en) 2012-05-18 2019-10-29 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US20140072959A1 (en) 2012-09-12 2014-03-13 Force Diagnostics, Inc. Rapid tests for insurance underwriting
CN105051542A (en) * 2012-10-31 2015-11-11 阿斯图德医疗有限公司 Quantitative lateral flow assay
CN105102980B (en) 2013-02-26 2017-11-03 阿斯图特医药公司 Lateral flow assays with strip keeper
CN108864232B (en) 2013-03-15 2022-01-04 伊鲁米纳剑桥有限公司 Modified nucleosides or nucleotides
CN108051590B (en) 2013-09-13 2020-12-11 Symbolics有限责任公司 Lateral flow assay using two-dimensional test and control signal readout modes
JP6286966B2 (en) * 2013-09-18 2018-03-07 コニカミノルタ株式会社 RESIN PARTICLE FOR FLUORESCENT LABELING, PROCESS FOR PRODUCING THE SAME, AND FLUORESCENT LABELING AGENT FOR IMMUNO STAINING CONTAINING THE SAME
US20180106799A1 (en) 2015-04-06 2018-04-19 Bludiagnostics, Inc. A test device for detecting an analyte in a saliva sample and method of use
EP3676612A4 (en) * 2017-08-31 2021-05-26 Agilent Technologies, Inc. Composition for stabilization of antibody formulations containing percp
US20200363406A1 (en) * 2017-10-26 2020-11-19 The University Of Houston System Highly-specific assays
WO2021213321A1 (en) 2020-04-20 2021-10-28 Mgi Tech Co., Ltd. Dna protection agent in dna imaging buffer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283382A (en) 1977-12-28 1981-08-11 Eastman Kodak Company Fluorescent labels comprising rare earth chelates
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5075215A (en) 1984-06-11 1991-12-24 Dreyer William J Use of daylight fluorescent pigments for tagging biological molecules
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US4876190A (en) 1987-10-21 1989-10-24 Becton Dickinson & Company Peridinin-chlorophyll complex as fluorescent label
DE3919393A1 (en) * 1989-06-14 1990-12-20 Hoechst Ag METHOD FOR STABILIZING SOLUBLE-IMMOBILIZED BIOLOGICAL ACTIVE SUBSTANCES
DE4004296A1 (en) * 1990-02-13 1991-08-14 Hoechst Ag IMPROVED MARKED HAPTENE, METHOD FOR THE PRODUCTION THEREOF AND USE OF THIS MARKED HAPTENE IN IMMUNOASSAYS
US5747334A (en) * 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5227487A (en) * 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
DE69132750T2 (en) * 1990-05-15 2002-06-20 Hyperion Inc FLUORESCENT PORPHYRIN AND FLUORESCENT PHTHALOCYANIN-POLYETHYLENE GLYCOL, POLYOL AND SACCHARID DERIVATIVES AS FLUORESCENT PROBE
DE69125992T2 (en) * 1990-09-14 1997-08-21 Tosoh Corp Method and kit for immunoassay
ATE177841T1 (en) * 1991-04-10 1999-04-15 Biosite Diagnostics Inc CROSSTALK OR CROSSTALK INHIBITORS AND THEIR USE
US5230836A (en) * 1991-06-20 1993-07-27 Kalamazoo Holdings, Inc. Low micron-sized ascorbic acid particles, especially a suspension thereof in a medium in which they are insoluble, and the use thereof as an antioxidant for mediums in which the particles remain insoluble
ATE162892T1 (en) * 1992-07-31 1998-02-15 Behringwerke Ag PHOTOACTIVABLE CHEMILUMINIZING MATRICES
US6251687B1 (en) * 1993-09-24 2001-06-26 Biosite Diagnostics, Inc. Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
EP0796108A2 (en) * 1994-12-06 1997-09-24 Ryan Pharmaceuticals, Inc. Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
US5650512A (en) * 1995-06-07 1997-07-22 Systemix Fluorescent labeling reagents
US5798276A (en) * 1995-06-07 1998-08-25 Molecular Probes, Inc. Reactive derivatives of sulforhodamine 101 with enhanced hydrolytic stability

Also Published As

Publication number Publication date
JP2001519908A (en) 2001-10-23
ATE244404T1 (en) 2003-07-15
CA2286183C (en) 2008-11-18
US7588908B2 (en) 2009-09-15
EP0972194A2 (en) 2000-01-19
DE69816051D1 (en) 2003-08-07
US6544797B1 (en) 2003-04-08
WO1998045705A3 (en) 1998-12-30
US20030129642A1 (en) 2003-07-10
EP0972194B1 (en) 2003-07-02
AU6796598A (en) 1998-10-30
WO1998045705A2 (en) 1998-10-15
DE69816051T2 (en) 2004-05-19

Similar Documents

Publication Publication Date Title
CA2286183A1 (en) Compositions and methods for inhibiting light-induced inactivation of biological reagents
CY1106984T1 (en) A NEW BIOLOGICAL COMPOSITION THAT CONTAINS A BIOLOGICAL POLYPHENOLIC PROTEIN, A POLYMER CONTAINING LIGHT CARBON GROUPS
BG101095A (en) Polyethyleneglycolizing reagents and compounds produced by them
CA2245066A1 (en) Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
BR9808491A (en) Calcilic compounds
CA2255637A1 (en) Conjugates of cis-docosahexaenoic acid and paclitaxel
DE69331774T2 (en) 7-Substituted-8-substituted-9-substituted amino-7-demethyl-6-deoxy-tetracyclines as antibiotic agents
ATE299145T1 (en) NEW MULTIMERIZING REAGENT
FI960546A (en) Stabilization of the polymer with a stable free radical
DE69535037D1 (en) Microbial transglutaminases, their preparation and their use
DE69608129T2 (en) ETHYLENIC-UNSATURATED 1,3-DIKETOAMID FUNCTIONAL COMPOUNDS, POLYMERS THEREOF AND THE LATEX COMPOSITION CONTAINING THEM
WO1994020551A3 (en) Polymeric mordants for dyes and the like
FI925988A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV B-LAKTAMER
AU1292899A (en) Pyrimidine derivatives for labeled binding partners
EP1452540A3 (en) Molecular sequence of swine retrovirus and methods of use
EP0283206A3 (en) Covalently labeled siloxane polymers
ATE240953T1 (en) CARBAZOL CARBOXAMIDE AS 5-HT1F AGONISTS
CA2211385A1 (en) N-1-carboxyalkyl derivatives of lsd
PL326926A1 (en) Chemical process
ID25478A (en) AGONIC 5-HT1F
CA2168731A1 (en) Antiparasitic Agents
PT1141069E (en) COATING COMPOSITION
AUPO470197A0 (en) Fluorescent dyes from microorganisms
CA2225485A1 (en) Microbiological degradation of alkylene amine acetates
IT1291320B1 (en) PROCEDURE FOR THE PREPARATION OF AROMATIC COMPOUNDS CONTAINING A HETEROCYCLIC SYSTEM

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180406